Clinical Trial Update: Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC) [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study of a prototype CS6 subunit vaccine with a modified heat-labile toxin from Enterotoxigenic Escherichia coli (ETEC) completed; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Drugs mentioned

• Prototype CS6 subunit vaccine with a modified heat-labile enterotoxin (LT) from Enterotoxigenic Escherichia coli (ETEC)

Snippet

Sponsor: PATH | Conditions: Diarrhea | Phase 1 | Status: COMPLETED | Results posted: 2021-01-06